101 related articles for article (PubMed ID: 33836311)
1. Prospective Randomized Study of Advance Directives in Allogeneic Hematopoietic Cell Transplantation Recipients.
Tan IT; Sundaram V; Ramirez Y; Burnash S; Kate Tierney D; Muffly LS
Transplant Cell Ther; 2021 Jul; 27(7):615.e1-615.e7. PubMed ID: 33836311
[TBL] [Abstract][Full Text] [Related]
2. Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Cappell K; Sundaram V; Park A; Shiraz P; Gupta R; Jenkins P; Periyakoil VSJ; Muffly L
Biol Blood Marrow Transplant; 2018 May; 24(5):1035-1040. PubMed ID: 29371107
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.
Lin RJ; Cohen AG; Stabler SM; Devlin SM; Elko TA; Maloy MA; Korc-Grodzicki B; Alexander K; Kramer D; Sanchez-Escamilla M; Castillo Flores N; Barker JN; Cho C; Dahi PB; Gyurkocza B; Papadopoulos EB; Perales MA; Politikos I; Ponce DM; Sauter CS; Scordo M; Shaffer BC; Shah GL; Tamari R; Young JW; Jakubowski AA; Giralt SA; Nelson JE
J Palliat Med; 2020 Dec; 23(12):1653-1657. PubMed ID: 32216649
[No Abstract] [Full Text] [Related]
4. Randomized Controlled Trial of Isha Kriya versus Observation to Improve Quality of Life in Hematopoietic Cell Transplantation Recipients.
Chopra M; Naik RR; Naik R; Sahni J; Bala K; Ahlawat J; Anand A; Singh C; Jandial A; Jain A; Prakash G; Khadwal A; Malhotra P; Lad DP
Transplant Cell Ther; 2023 Aug; 29(8):530.e1-530.e5. PubMed ID: 37192731
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Controlled Trial Comparing the Letter Project Advance Directive to Traditional Advance Directive.
Periyakoil VS; Neri E; Kraemer H
J Palliat Med; 2017 Sep; 20(9):954-965. PubMed ID: 28471713
[TBL] [Abstract][Full Text] [Related]
7. Advance care planning in patients undergoing hematopoietic cell transplantation.
Joffe S; Mello MM; Cook EF; Lee SJ
Biol Blood Marrow Transplant; 2007 Jan; 13(1):65-73. PubMed ID: 17222754
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.
Elsawy M; Storer BE; Milano F; Sandmaier BM; Delaney C; Salit RB; Rashad AH; Woolfrey AE; Appelbaum FR; Storb R; Sorror ML
Biol Blood Marrow Transplant; 2019 May; 25(5):1045-1052. PubMed ID: 30500442
[TBL] [Abstract][Full Text] [Related]
9. A Three-Step Letter Advance Directive Procedure to Facilitate Patient-Proxy Alignment in Advance Care Planning.
Alagappan M; Richardson MT; Schoen MK; Muffly L; Tierney K; Jenkins P; Neri E; Kraemer HC; Periyakoil VS
J Palliat Med; 2018 Dec; 21(12):1749-1754. PubMed ID: 30247088
[No Abstract] [Full Text] [Related]
10. A Randomized Trial of Expanding Choice Sets to Motivate Advance Directive Completion.
Courtright KR; Madden V; Gabler NB; Cooney E; Kim J; Herbst N; Burgoon L; Whealdon J; Dember LM; Halpern SD
Med Decis Making; 2017 Jul; 37(5):544-554. PubMed ID: 27510741
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Determinants of completion of advance directives: a cross-sectional comparison of 649 outpatients from private practices versus 2158 outpatients from a university clinic.
Pfirstinger J; Bleyer B; Blum C; Rechenmacher M; Wiese CH; Gruber H
BMJ Open; 2017 Dec; 7(12):e015708. PubMed ID: 29273648
[TBL] [Abstract][Full Text] [Related]
13. Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant.
Higgins A; Khan Z; Coddington CC; Hashmi SK; Hefazi M; Alkhateeb H; Litzow MR; Hogan WJ; Cathcart-Rake E; Thompson CA; Patnaik MM
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1232-1239. PubMed ID: 30772513
[TBL] [Abstract][Full Text] [Related]
14. The effect of advance care planning on completion of advance directives and patient satisfaction in people with HIV/AIDS.
Ho VW; Thiel EC; Rubin HR; Singer PA
AIDS Care; 2000 Feb; 12(1):97-108. PubMed ID: 10716022
[TBL] [Abstract][Full Text] [Related]
15. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881
[TBL] [Abstract][Full Text] [Related]
16. Home-Based Hematopoietic Cell Transplantation in the United States.
Sung AD; Giri VK; Tang H; Nichols KR; Lew MV; Bohannon L; Ren Y; Jung SH; Dalton T; Bush A; Van Opstal J; Artica A; Messina J; Shelby R; Frith J; Lassiter M; Burleson J; Leonard K; Potter AS; Choi T; Gasparetto CJ; Horwitz ME; Long GD; Lopez RD; Sarantopoulos S; Chao NJ
Transplant Cell Ther; 2022 Apr; 28(4):207.e1-207.e8. PubMed ID: 35066211
[TBL] [Abstract][Full Text] [Related]
17. Modifiable Factors Associated with the Completion of Advance Treatment Directives in Hematologic Malignancy: A Patient-Caregiver Dyadic Analysis.
Kim J; Park J; Lee MO; Park EY; Heo S; Shim JL
J Palliat Med; 2020 May; 23(5):611-618. PubMed ID: 31855491
[No Abstract] [Full Text] [Related]
18. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.
Dubberke ER; Reske KA; Olsen MA; Bommarito K; Cleveland AA; Silveira FP; Schuster MG; Kauffman CA; Avery RK; Pappas PG; Chiller TM
Transpl Infect Dis; 2018 Apr; 20(2):e12855. PubMed ID: 29427356
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients.
Hamilton BK; Law AD; Rybicki L; Abounader D; Dabney J; Dean R; Duong HK; Gerds AT; Hanna R; Hill BT; Jagadeesh D; Kalaycio ME; Lawrence C; McLellan L; Pohlman B; Sobecks RM; Bolwell BJ; Majhail NS
Bone Marrow Transplant; 2015 Sep; 50(9):1235-40. PubMed ID: 26030045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
